Download PDF
Semin Liver Dis 2009; 29(3): 254-261
DOI: 10.1055/s-0029-1233532
© Thieme Medical Publishers

Scoring Systems for the Diagnosis of Autoimmune Hepatitis: Past, Present, and Future

Christiane Wiegard1 , Christoph Schramm1 , Ansgar W. Lohse1
  • 1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Further Information

Publication History

Publication Date:
12 August 2009 (online)

    Permissions and Reprints

ABSTRACT

The diagnosis of autoimmune hepatitis (AIH) can be challenging due to the variable clinical and laboratory findings. The original diagnostic criteria published in 1993 by the International Autoimmune Hepatitis Group (IAIHG) were revised in 1999 in an attempt to standardize the diagnosis. However, these criteria are complex and can be cumbersome in clinical practice. In 2008, simplified diagnostic criteria were reported to facilitate the bedside diagnosis of AIH. The scoring systems have been evaluated in several retrospective case series and tested for their ability to reliably diagnose and exclude AIH. However, the scoring systems did not fare as well in patients with concomitant cholestatic disease, fatty liver disease, fulminant hepatitis, and pediatric patients. Both positive and negative predictive values are low in these patients. Prospective studies are needed to compare the two scoring systems to determine which (if not all) patients require liver biopsy and which patients would benefit from immunotherapy.

KEYWORDS

Autoimmune hepatitis - revised original scoring system - simplified scoring system

REFERENCES

  • 1 Johnson P J, McFarlane I G. Meeting report: International Autoimmune Hepatitis Group.  Hepatology. 1993;  18(4) 998-1005
    CrossrefPubMedGoogle Scholar
  • 2 Alvarez F, Berg P A, Bianchi F B et al.. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.  J Hepatol. 1999;  31(5) 929-938
    CrossrefPubMedGoogle Scholar
  • 3 Hennes E M, Zeniya M, Czaja A J International Autoimmune Hepatitis Group et al. Simplified criteria for the diagnosis of autoimmune hepatitis.  Hepatology. 2008;  48(1) 169-176
    CrossrefPubMedGoogle Scholar
  • 4 Dickson R C, Gaffey M J, Ishitani M B, Roarty T P, Driscoll C J, Caldwell S H. The international autoimmune hepatitis score in chronic hepatitis C.  J Viral Hepat. 1997;  4(2) 121-128
    PubMedGoogle Scholar
  • 5 Czaja A J, Carpenter H A. Validation of scoring system for diagnosis of autoimmune hepatitis.  Dig Dis Sci. 1996;  41(2) 305-314
    CrossrefPubMedGoogle Scholar
  • 6 Bianchi F B, Cassani F, Lenzi M et al.. Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis. An Italian experience.  Dig Dis Sci. 1996;  41(1) 166-171
    CrossrefPubMedGoogle Scholar
  • 7 Toda G, Zeniya M, Watanabe F Japanese National Study Group of Autoimmune Hepatitis et al. Present status of autoimmune hepatitis in Japan—correlating the characteristics with international criteria in an area with a high rate of HCV infection.  J Hepatol. 1997;  26(6) 1207-1212
    CrossrefPubMedGoogle Scholar
  • 8 Miyakawa H, Kitazawa E, Abe K et al.. Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis.  J Gastroenterol. 1997;  32(6) 769-776
    CrossrefPubMedGoogle Scholar
  • 9 Boberg K M, Fausa O, Haaland T et al.. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.  Hepatology. 1996;  23(6) 1369-1376
    CrossrefPubMedGoogle Scholar
  • 10 Omagari K, Masuda J, Kato Y et al.. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group.  Intern Med. 2000;  39(12) 1008-1012
    CrossrefPubMedGoogle Scholar
  • 11 Chazouillères O. Diagnosis of primary sclerosing cholangitis—autoimmune hepatitis overlap syndrome: to score or not to score?.  J Hepatol. 2000;  33(4) 661-663
    CrossrefPubMedGoogle Scholar
  • 12 Yatsuji S, Hashimoto E, Kaneda H, Taniai M, Tokushige K, Shiratori K. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?.  J Gastroenterol. 2005;  40(12) 1130-1138
    CrossrefPubMedGoogle Scholar
  • 13 van Buuren H R, van Hoogstraten H JE, Terkivatan T, Schalm S W, Vleggaar F P. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis.  J Hepatol. 2000;  33(4) 543-548
    CrossrefPubMedGoogle Scholar
  • 14 Kaya M, Angulo P, Lindor K D. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system.  J Hepatol. 2000;  33(4) 537-542
    CrossrefPubMedGoogle Scholar
  • 15 Talwalkar J A, Keach J C, Angulo P, Lindor K D. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system.  Am J Gastroenterol. 2002;  97(5) 1191-1197
    CrossrefPubMedGoogle Scholar
  • 16 Farias A Q, Gonçalves L L, Bittencourt P L et al.. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis.  J Gastroenterol Hepatol. 2006;  21(5) 887-893
    CrossrefPubMedGoogle Scholar
  • 17 O'Brien C, Joshi S, Feld J J, Guindi M, Dienes H P, Heathcote E J. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis.  Hepatology. 2008;  48(2) 550-556
    CrossrefPubMedGoogle Scholar
  • 18 Papamichalis P A, Zachou K, Koukoulis G K et al.. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.  J Autoimmune Dis. 2007;  4 3
    CrossrefPubMedGoogle Scholar
  • 19 Choi G, Peters M G. Autoimmune hepatitis: effect of age on severity of disease and use of new scoring system. 2008 American Association for the Study of Liver Diseases San Francisco, CA; October 31–November 4, 2008
    Google Scholar
  • 20 Yeoman A D, Westbrook R H, Al-Chalabi T, Portmann B C, Heneghan M A. Validation and utility of the new simplified international autoimmune hepatitis group (IAIHG) criteria: an assessment of sensitivity and specificity. 2008 American Association for the Study of Liver Diseases San Francisco, CA; October 31–November 4, 2008
    Google Scholar
  • 21 Muratori P, Granito A, Pappas G, Muratori L. Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients.  Hepatology. 2009;  49(5) 1782-1783 , author reply 1783
    CrossrefPubMedGoogle Scholar
  • 22 Czaja A J. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis.  Hepatology. 2008;  48(5) 1540-1548
    CrossrefPubMedGoogle Scholar
  • 23 Hennes E, Schramm C, Lohse A W. Reply to letter: validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients.  Hepatology. 2009;  49(5) 1783
    PubMedGoogle Scholar
  • 24 Denzer U, Helmreich-Becker I, Galle P R, Lohse A W. Liver assessment and biopsy in patients with marked coagulopathy: value of mini-laparoscopy and control of bleeding.  Am J Gastroenterol. 2003;  98(4) 893-900
    CrossrefPubMedGoogle Scholar
  • 25 Yeoman A D, Al-Chalabi T, Karani J B et al.. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening.  Hepatology. 2008;  48(3) 863-870
    CrossrefPubMedGoogle Scholar
  • 26 Mieli-Vergani G, Vergani D. Autoimmune paediatric liver disease.  World J Gastroenterol. 2008;  14(21) 3360-3367
    CrossrefPubMedGoogle Scholar

Ansgar W LohseM.D. 

I. Department of Medicine, University Medical Center Hamburg-Eppendorf

Martinistrasse 52, D-20246 Hamburg, Germany

Email: alohse@uke.de

      >